hims hers - Search News

Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration (FDA) on Monday.

AOL · 6d

This Could Be a Huge Blow to Hims & Hers Health Stock

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% during that stretch. A big opportunity lately has been in helping people access GLP-1 weight loss drugs,

Zacks.com on MSN · 2d

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The Motley Fool on MSN · 2d

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is taking investors on a roller-coaster ride in 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

6don MSN

Hims & Hers to shut down dermatology business Apostrophe

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...

Why Hims & Hers Stock Just Collapsed

Hims & Hers Health ( HIMS -12.79%) stock took a tumble Thursday morning, falling 9.2% through 11:40 a.m. ET on some ...

Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...

Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

8don MSN

Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Fierce Healthcare2d

Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

Hims & Hers: AI-Powered Healthcare Disruption

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Money Morning6d

Hims & Hers Tumbles on Discounted Wegovy

Shares of Hims & Hers Health ( HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its ...

Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics